Wordt geladen...
Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis
The use of TNF-alpha antagonists (infliximab, etanercept, adalimumab) has changed the course of many rheumatic diseases including rheumatoid arthritis (RA). Since their approval, some questions regarding their safety including infections have been observed. The aim of the study was to evaluate the c...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Bentham Open
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3362853/ https://ncbi.nlm.nih.gov/pubmed/22655000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312901206010033 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|